Cardiology

This episode navigates atherosclerotic cardiovascular disease, including plaque morphology, residual risk, secondary treatment options, and guidelines from the National Institute for Health and Care Excellence.

Discussing the burden of hypertrophic cardiomyopathy (HCM), experts in this field shed light on the diagnosis and treatment of HCM.

This podcast focuses on one particular treatment, mexiletine, to understand how the medication’s cardiac side-effects could affect how it is prescribed.

This podcast episode explores new advances in treating obstructive hypertrophic cardiomyopathy (HCM) and the role of myosin inhibitors.

This episode explores various aspects of obstructive hypertrophic cardiomyopathy (HCM), and features expert insights from Antonis Pantazis.

This week, Jonathan Sackier is joined by Rebecca Dobson, Consultant Cardio-Oncologist at the Heart & Chest Hospital, Liverpool, UK.

This EMJ podcast explores the vital topic of low-density lipoprotein cholesterol (LDL-C) management in relation to the treatment and prevention of atherosclerotic cardiovascular disease. Our host, George Cooper, is joined by Michal Vrablík.

In this episode, Jonathan spoke with David Hildick-Smith, the pair discussed all things cardiology, with a key focus on interventional surgery